Eclipta prostrata L. phytochemicals: Isolation, structure elucidation, and their antitumor activity

Food and Chemical Toxicology

Volumn 50, Issue 11, 2012, Pages 4016-4022

  Liu, Qi Mei ^a   Zhao, Hai Yan ^b   Zhong, Xian Ke ^a   Jiang, Jian Guo ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b Xinjiang Lvxiang Sugar Co Ltd   (China)

Author keywords

Antitumor activity; Eclipta prostrata L.; Phytochemicals; Structure identification

Indexed keywords

ECLALBASAPONIN I; FLUOROURACIL; LUTEOLIN; LUTEOLIN 7 GLUCOSIDE; PLANT MEDICINAL PRODUCT; RESIN; SEPHADEX; SILICA GEL; SOLVENT; UNCLASSIFIED DRUG; WEDELOLACTONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARBON NUCLEAR MAGNETIC RESONANCE; CELL ASSAY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; DRUG PURIFICATION; DRUG STRUCTURE; ECLIPTA; ECLIPTA PROSTRATA; FRACTIONATION; HEPATOMA CELL; IC 50; IN VITRO STUDY; MASS SPECTROMETRY; PHYTOCHEMISTRY; PLANT LEAF; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS; THIN LAYER CHROMATOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHINA; COUMARINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ECLIPTA; FLAVONES; GLUCOSIDES; HUMANS; LIVER NEOPLASMS; LUTEOLIN; MEDICINE, CHINESE TRADITIONAL; MOLECULAR STRUCTURE; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; PLANTS, MEDICINAL; SAPONINS;

ASTERACEAE; ECLIPTA PROSTRATA;

EID: 84866150201     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.08.007     Document Type: Article

References (32)

1. Arunachalam G., Subramanian N., Pazhani G.P., Ravichandran V. Anti-inflammatory activity of methanolic extract of Eclipta prostrata L. (Astearaceae). Afr. J. Pharm. Pharmacol. 2009, 3(3):97-100.
2. Baskar A.A., Iqnacimuthu S., Michael G.P., Al Numair K.S. Cancer chemopreventive potential of luteolin-7-O-glucoside isolated from Ophiorrhiza mungos Linn. Nutr. Cancer 2011, 63(1):130-138.
3. Benes P., Knopfova L., Trcka F., Nemajerova A., Pinheiro D., Soucek K., Fojta M., Smarda J. Inhibition of topoisomerase II α: novel function of wedelolactone. Cancer Lett. 2011, 303(1):29-38.
4. Dalal S., Kataria S.K., Sastry K.V., Rana S.V.S. Phytochemical screening of methanolic extract and antibacterial activity of active principles of hepatoprotective herb Eclipta alba. Ethnobot. Leaflets 2010, 14:248-258.
5. Dhandapani R. Hypolipidemic activity of Eclipta prostrata (L.) L. leaf extract in atherogenic diet induced hyperlipidemic rats. Indian J. Exp. Biol. 2007, 45(7):617-619.
6. Diasio R.B., Harris B.E. Clinical pharmacology of 5-fluorouracil. Clin. Pharmacokinet. 1989, 16(4):215-252.
7. Khanna V.G., Kannabiran K. Antimicrobial activity of saponin fractions of the leaves of Gymnema sylvestre and Eclipta prostrata. Chem. Mater. Sci. 2008, 24(11):2737-2740.
8. Khanna V.G., Kannabiran K. Anticancer-cytotoxic activity of saponins isolated from the leaves of Gymnema sylvestre and Eclipta prostrata on Hela cells. Int. J. Green Pharm. 2009, 3(3):227-229.
9. Kim D.I., Lee S.H., Choi J.H., Lillehoj H.S., Yu M.H., Lee G.S. The butanol fraction of Eclipta prostrata (Linn) effectively reduces serum lipid levels and improves antioxidant activities in CD rats. Nutr. Res. 2008, 28(8):550-554.
10. Kobori M., Yang Z., Gong D., Heissmeyer V., Zhu H., Jung Y.K., Gakidis M.A.M., Rao A., Sekine T., Ikegami F., Yuan C., Yuan J. Wedelolactone suppresses LPS-induced caspase 11 expression by directly inhibiting the IKK complex. Cell Death Differ. 2004, 11(1):123-130.
11. La V.D., Labrecque J., Grenier D. Cytoprotective effect of proanthocyanidin-rich cranberry fraction against bacterial cell wall-mediated toxicity in macrophages and epithelial cell. Phytother. Res. 2009, 23(10):1449-1452.
12. Lee M.K., Ha N.R., Yang H., Sung S.H., Kim G.H., Kim Y.C. Antiproliferative activity of triterpenoids from Eclipta prostrata on hepatic stellate cells. Phytomedicine 2007, 15(9):775-780.
13. Li J., Wang Y.X. Advances in studies on chemical constituents and pharmacological effects of Eclipta prostrata. China Pharm. 2010, 13(8):1193-1194.
14. Lin Y., Shi R.X., Wang X., Shen H.M. Luteolin, a flavonoid with potentials for cancer prevention and therapy. Curr. Cancer Drug Targets 2008, 8(7):634-646.
15. Liu X., Jiang Y., Tang H. Effect of ethyl acetate extract of Eclipta prostrata on mice of normal and immunosupression. J. Chin. Med. Mater. 2000, 23(7):407-409.
16. Lu C.L., Li Y.M., Fu G.Q., Yang L., Jiang J.G., Zhu L., Lin F.L., Chen J., Lin Q.S. Extraction optimization of daphnoretin from root bark of Wikstroemia indica (L.) C.A. and its anti-tumour activity tests. Food Chem. 2011, 124(4):1500-1506.
17. Mors W.B., do Nascimento M.C., Parente J.P., da Silva M.H., Melo P.A., Suarez-Kurtz G. Neutralization of lethal and myotoxic activities of South American rattlesnake venom by extracts and constituents of the plant Eclipta prostrata (Asteraceae). Toxicon 1989, 27(9):1003-1009.
18. Muthu M.S., Kulkarni S.A., Xiong J.Q., Feng S.S. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int. J. Pharm. 2011, 421(2):332-340.
19. Pithayanukul P., Lapett B., Bavovada R., Pakmanee N. Inhibition of proteolytic and hemorrhagic activities by ethyl acetate extract of Eclipta prostrata against Malayan pit. Pharm. Biol. 2007, 45(4):282-288.
20. Prachayasittikul S., Wongsawatkul O., Suksrichavalit T., Ruchirawat S., Prachayasittikul V. Bioactivity evaluation of Eclipta prostrata Linn: a potential vasorelaxant. Eur. J. Sci. Res. 2010, 44(2):167-176.
21. Rahman M.S., Chowdhury R., Hasan C.M., Rashid M.A. Oleanane glycosides from Eclipta prostrata. Dhaka Univ. J. Pharm. Sci. 2005, 4(2):107-111.
22. Santhosh K.C., Govindasamy S., Sukumar E. Lipid lowering activity of Eclipta prostrata in experimental hyperlipidemia. J. Ethnopharmacol. 2006, 105(3):332-335.
23. Sawant M., Isaac J.C., Narayanan S. Analgesic studies on total alkacoloids and alcohol extracts of Eclipta alba (Linn.) Hassk. Phytother. Res. 2004, 18:111-113.
24. Syed S.D., Deepak M.E., Yogisha S., Chandrashekar A.P., Muddarachappa K.A., D'Souza P., Agarwal A., Venkatataraman B.V. Trypsin inhibitory effect of wedelolactone and demethylwedelolactone. Phytother. Res. 2003, 17(4):420-421.
25. Tavakkol-Afshari J., Brook A., Mousavi S.H. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem. Toxicol. 2008, 46(11):3443-3447.
26. Tewtrakul S., Subhadhirasakul S., Tansakul P., Cheenpracha S., Karalai C. Antiinflammatory constituents from Eclipta prostrata using RAW 264.7 Macrophage cells. Phytother. Res. 2011, 25:1313-1316.
27. Thakur V.D., Mengi S.A. Neuropharmacological profile of Eclipta alba (Linn.) Hassk. J. Ethnopharmacol. 2005, 102(1):23-31.
28. Wagner H., Bauer R., Melchart D. Herba Ecliptae Mohanlian. Chromatogr. Fingerprint Analysis Herbal Med. 2011, 1:263-271.
29. Yahara S., Ding N., Nohara T. Oleanane glycosides from Eclipta alba. Chem. Pharm. Bull. 1994, 42(6):1336-1338.
30. Yahara S., Ding N., Nohara T., Masuda K., Ageta H. Taraxastane glycosides from Eclipta alba. Phytochemistry 1997, 44(1):131-135.
31. Ying D.L. The research progress in chemical constituents, pharmacological effects and clinic application of Eclipta prostrata. China Pharm. 2008, 19(36):2876-2877.
32. Zhong X.K., Li D.C., Jiang J.G. Identification and Quality Control of Chinese Medicine Based on the Fingerprint Techniques. Curr. Med. Chem. 2009, 16(23):3064-3075.